BIODRUGS

Biodrugs is a distinguished international peer-reviewed journal dedicated to the comprehensive study of biopharmaceuticals, published by Springer Nature in New Zealand with the ISSN 1173-8804. Appearing as a bimonthly publication, the journal maintains a high impact factor and is indexed in the Science Citation Index (SCI), consistently ranking within the second or third quartile of the Chinese Academy of Sciences journal classification in the fields of medicine and pharmacy. The scope of Biodrugs encompasses critical areas such as the development and clinical application of biologic drugs, biosimilars, monoclonal antibodies, gene therapies, and the safety evaluation of biopharmaceuticals, with a particular emphasis on the translational medicine aspects of innovative biotherapies. As a high-quality publication with rigorous peer-review standards, the journal prioritizes research that demonstrates significant novelty and clinical relevance, although authors should be mindful of its relatively high rejection rate and potentially longer publication timelines. While the journal operates on a subscription-based model, it offers optional open access for selected articles, catering to a global audience of researchers, clinicians, and pharmaceutical professionals seeking authoritative insights into the evolving landscape of biologic therapeutics.